Application of lamprey CRBGP in preparation of drug for resisting malignant glioma
A technology for malignant glioma and lamprey, which is applied in the direction of anti-tumor drugs, drug combinations, and pharmaceutical formulations, and can solve the problems of anti-glioblastoma drugs that have not yet been seen
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0067] 1. Purification of native CRBGP
[0068] The lampreys were sacrificed, their oral glands were stripped off, and the liquid in the oral glands was sucked out with a syringe at -80°C for storage. The extracted liquid was diluted to 24 mg / ml with a buffer solution containing 50 mM Tris-HCl and 50 mM NaCl (pH 7.4), and then centrifuged at 10,000 rpm for 10 min at 4°C to obtain the supernatant. About 380 μl of supernatant was added to a 1-meter-long Sephadex G-75 chromatography column, the sample flow rate was 700 μl / min, and about 1.2 ml of eluate was collected in each Eppendor tube. The purity of the protein was detected by 12% polyacrylamide gel electrophoresis (SDS-PAGE), and the concentration of the protein was determined by the BCA method.
[0069] 2. Expression and purification of recombinant CRBGP
[0070] (1) The CRBGP gene with the signal peptide removed and the vector pEGX-4T-1 were double-enzymatically digested, ligated overnight at 16°C, and the ligated prod...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com